Recent studies have revealed that METTL3 upregulates PLAU mRNA in a manner dependent on m6A modification and is involved in the MAPK/ERK pathway, promoting angiogenesis and metastasis in CRC. This evidence concerns the gene METTL3 and colorectal carcinoma.